Author:
Darbà Josep,Farrés Agnès Minoves
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference27 articles.
1. Dicato M. Anemia in cancer: some pathophysiological aspects. Oncologist 2003;8(Suppl 1):19–21.
2. Mercadante S, Gebbia V, Marrazzo A, Filosto S. Anemia in cancer: pathophysiology and treatment. Cancer Treat Rev 2000; 26:303–11.
3. Glaspy JA, Jadeja JS et al.Arandomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease. Cancer 2003; 97:1312–20.
4. Evans WJ. Physical function in men and women with cancer. Effects of anemiaand conditioning. Oncology (Williston Park) 2002;16:109–115
5. Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 1998; 12:369–77.